Advertisement
GLUE Novinky na Forexu
Monte Rosa Therapeutics Inks Strategic Collaboration With Roche To Develop Molecular Glue Degraders
Biotechnology company Monte Rosa Therapeutics, Inc. (GLUE) announced Tuesday it has entered into a strategic collaboration and licensing agreement with Roche Holding AG to discover and develop MGDs against targets in cancer and neurological diseases.
RTTNews
|
Před 575 dny